Carregant...
Topical Ranibizumab as a Treatment of Corneal Neovascularization
PURPOSE: To examine the effect of topical ranibizumab on clinically stable corneal neovascularization (NV). METHODS: This was a prospective, open-label, monocentric, uncontrolled, non-comparative study. Ten eyes of 9 patients with corneal NV received topical ranibizumab (1%) 4 times a day for 3 week...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3920979/ https://ncbi.nlm.nih.gov/pubmed/23407316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/ICO.0b013e3182775f8d |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|